Table 1.
Main characteristics of the studied population with malignant breast tumours (n = 72)
| n (%) | ||
|---|---|---|
| Histological classification | Ductal in situ | 2/72 (2·7) |
| Infiltrative ductal | 60/72 (83·3) | |
| Infiltrative lobular | 4/72 (5·5) | |
| Infiltrative ductolobular | 4/72 (5·5) | |
| Phyloid tumour | 1/72 (1·3) | |
| Infiltrative papillary | 1/72 (1·3) | |
| Staging | In situ | 7/57 (12·2) |
| I | 8/57 (14·0) | |
| II | 13/57 (22·8) | |
| III | 8/57 (14·0) | |
| IV | 21/57 (36·8) | |
| Oestrogen receptor‐positive | 42/62 (67·7) | |
| Progesterone receptor‐positive | 39/62 (62·9) | |
| Luminal A | 12/55 (21·8) | |
| Luminal B | 26/55 (47·2) | |
| Hormonal receptor‐positive* | 42/65 (64·2) | |
| HER2‐positive | 7/55 (12·7) | |
| Triple‐negative | 10/55 (18·1) | |
| Smokers | 6/45 (13·3) | |
| Mean body mass index | 27·42 ± 4·87 kg/m2 | |
*Hormonal receptor‐positive = to oestrogen or oestrogen + progesterone receptor‐positive. HER2 = human epidermal growth factor receptor 2.